Related references
Note: Only part of the references are listed.Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks
Kimberly K. Scarsi et al.
CLINICAL INFECTIOUS DISEASES (2016)
The safety of hormonal contraceptives for women living with HIV and their sexual partners
Sharon J. Phillips et al.
CONTRACEPTION (2016)
Typical-use contraceptive failure rates in 43 countries with Demographic and Health Survey data: summary of a detailed report
Chelsea B. Polis et al.
CONTRACEPTION (2016)
High Variability of Hormonal Levels and No Clinically Relevant Interaction Between Ethinyl Estradiol, Desogestrel and Lopinavir/Ritonavir in a Small Sample of HIV-positive Adolescents
Nadia Kancheva Landolt et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy
Maria Pyra et al.
AIDS (2015)
Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol
Ivy H. Song et al.
ANNALS OF PHARMACOTHERAPY (2015)
Depot Medroxyprogesterone Acetate in Combination with a Twice-Daily Lopinavir-Ritonavir-Based Regimen in HIV-Infected Women Showed Effective Contraception and a Lack of Clinically Significant Interactions, with Good Safety and Tolerability: Results of the ACTG 5283 Study
Amneris E. Luque et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Progesterone-Based Intrauterine Device Use Is Associated with a Thinner Apical Layer of the Human Ectocervical Epithelium and a Lower ZO-1 mRNA Expression
Annelie Tjernlund et al.
BIOLOGY OF REPRODUCTION (2015)
Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya
Catherine S. Todd et al.
CONTRACEPTION (2015)
Increased exposure of norethindrone in HIV plus women treated with ritonavir-boosted atazanavir therapy
Barent N. DuBois et al.
CONTRACEPTION (2015)
Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study
Rena C. Patel et al.
LANCET HIV (2015)
Pharmacokinetic and Pharmacodynamic Drug Interactions Between Antiretrovirals and Oral Contraceptives
Victoria Tittle et al.
CLINICAL PHARMACOKINETICS (2015)
Differential Glucocorticoid Receptor-Mediated Effects on Immunomodulatory Gene Expression by Progestin Contraceptives: Implications for HIV-1 Pathogenesis
Janet P. Hapgood et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2014)
Worldwide use of intrauterine contraception: a review
Kai J. Buhling et al.
CONTRACEPTION (2014)
Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs
Richard P. H. Huijbregts et al.
CONTRACEPTION (2014)
Extended use of the intrauterine device: a literature review and recommendations for clinical practice
Justine P. Wu et al.
CONTRACEPTION (2014)
Lack of an effect of rilpivirine on the pharmacokinetics of ethinylestradiol and norethindrone in healthy volunteers
Herta M. Crauwels et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2014)
Effect of Antiretroviral Therapy Including Lopinavir/Ritonavir or Efavirenz on Etonogestrel-Releasing Implant Pharmacokinetics in HIV-Positive Women
Carolina S. Vieira et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
A Prospective Cohort Study of the Effect of Depot Medroxyprogesterone Acetate on Detection of Plasma and Cervical HIV-1 in Women Initiating and Continuing Antiretroviral Therapy
Summer Day et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Cervicovaginal HIV-1 Shedding in Women Taking Antiretroviral Therapy in Burkina Faso: A Longitudinal Study
Andrea J. Low et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Effect of Protease Inhibitors on Steady-State Pharmacokinetics of Oral Norethindrone Contraception in HIV-Infected Women
Jessica Atrio et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Significant Decrease of Ethinylestradiol With Nevirapine, and of Etonogestrel With Efavirenz in HIV-Positive Women
Nadia K. Landolt et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
ACOG Committee Opinion No. 450: Increasing Use of Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy
OBSTETRICS AND GYNECOLOGY (2014)
Effect of hormonal contraceptive methods on HIV disease progression: a systematic review
Sharon J. Phillips et al.
AIDS (2013)
Hormonal contraceptive use and risk of HIV-1 disease progression
Renee Heffron et al.
AIDS (2013)
Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence
Chelsea B. Polis et al.
AIDS (2013)
Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples
Tom Lutalo et al.
AIDS (2013)
Trends in contraceptive use
Jacqueline E. Darroch
CONTRACEPTION (2013)
Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical Effects
Frank Z. Stanczyk et al.
ENDOCRINE REVIEWS (2013)
Drug interactions between antiretrovirals and hormonal contraceptives
Alice Tseng et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Efavirenz, in Contrast to Nevirapine, is Associated With Unfavorable Progesterone and Antiretroviral Levels When Coadministered With Combined Oral Contraceptives
Nadia Kancheva Landolt et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Effect of the Levonorgestrel Intrauterine Device on Genital HIV-1 RNA Shedding Among HIV-1-Infected Women Not Taking Antiretroviral Therapy in Nairobi, Kenya
Jenell S. Coleman et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys
Jacqueline E. Darroch et al.
LANCET (2013)
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study
Renee Heffron et al.
LANCET INFECTIOUS DISEASES (2012)
The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study
Oskari Heikinheimo et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women
Jenny Zhang et al.
ANTIVIRAL THERAPY (2011)
The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women
Heather Sevinsky et al.
ANTIVIRAL THERAPY (2011)
Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women
Matt S. Anderson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Combined Oral Contraceptives and Antiretroviral PK/PD in Malawian Women: Pharmacokinetics and Pharmacodynamics of a Combined Oral Contraceptive and a Generic Combined Formulation Antiretroviral in Malawi
Gretchen S. Stuart et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Effect of Hormonal Contraceptive Use Before HIV Seroconversion on Viral Load Setpoint Among Women in Rakai, Uganda
Chelsea B. Polis et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Long-Acting Reversible Contraceptives Intrauterine Devices and the Contraceptive Implant
Eve Espey et al.
OBSTETRICS AND GYNECOLOGY (2011)
Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission
Jared M. Baeten et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda
Chelsea B. Polis et al.
AIDS (2010)
Contraceptive Efficacy of Oral and Transdermal Hormones When Co-Administered With Protease Inhibitors in HIV-1-Infected Women: Pharmacokinetic Results of ACTG Trial A5188
Mary A. Vogler et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Antiretroviral Adherence and Development of Drug Resistance Are the Strongest Predictors of Genital HIV-1 Shedding among Women Initiating Treatment
Susan M. Graham et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial
Elizabeth M. Stringer et al.
AIDS (2009)
Highly effective contraception and acquisition of HIV and other sexually transmitted infections
Charles S. Morrison et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2009)
Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone
Monika Scholler-Gyure et al.
CONTRACEPTION (2009)
Contraception and HIV infection in women
Oskari Heikinheimo et al.
HUMAN REPRODUCTION UPDATE (2009)
Lack of Effect of Tenofovir Disoproxil Fumarate on Pharmacokinetics of Hormonal Contraceptives
Brian P. Kearney et al.
PHARMACOTHERAPY (2009)
Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells
P. Martin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy
Kavita Nanda et al.
FERTILITY AND STERILITY (2008)
Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone
Tuomas Korhonen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Using an intrauterine device in immunocompromised women
Hyacinth Browne et al.
OBSTETRICS AND GYNECOLOGY (2008)
Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countries
H. W. Reynolds et al.
SEXUALLY TRANSMITTED INFECTIONS (2008)
Depo-medroxyprogesterone in women on antiretroviral therapy: Effective contraception and lack of clinically significant interactions
S. E. Cohn et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women
Paivi Lehtovirta et al.
CONTRACEPTION (2007)
Pharmacokinetic drug interactions involving 17 alpha-ethinylestradiol - A new look at an old drug
Hongjian Zhang et al.
CLINICAL PHARMACOKINETICS (2007)
The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women - effects on bleeding patterns, ovarian function and genital shedding of HIV
Oskari Heikinheimo et al.
HUMAN REPRODUCTION (2006)
The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine
Francesca T. Aweeka et al.
AIDS (2006)
The survival benefits of AIDS treatment in the United States
Rochelle P. Walensky et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
The value of contraception to prevent perinatal HIV transmission
Heidi W. Reynolds et al.
SEXUALLY TRANSMITTED DISEASES (2006)
Female sex and oral contraceptive use accelerate nicotine metabolism
Neal L. Benowitz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
The role of CYP2C and CYP3A in the disposition of 3-keto-desogestrel after administration of desogestrel
T Korhonen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women
L Lavreys et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
The involvement of CYP3A4 and CYP2C9 in the metabolism of 17α-ethinylestradiol
B Wang et al.
DRUG METABOLISM AND DISPOSITION (2004)
Inhibition of cytochrome P4502B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation
S Palovaara et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Viral load and heterosexual transmission of human immunodeficiency virus type 1
TC Quinn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
